Clinical review: Hyperandrogenism and polycystic ovary syndrome in women with type 1 diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 4, 2007, Pages 1209-1216

  Codner, Ethel ^a   Escobar Morreale, Héctor F ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; FLUTAMIDE; INSULIN; METFORMIN; ORAL CONTRACEPTIVE AGENT;

ANOVULATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HIRSUTISM; HORMONE ACTION; HUMAN; HYPERANDROGENISM; HYPERINSULINISM; INSULIN BINDING; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MENSTRUATION DISORDER; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; PATIENT MONITORING; PREVALENCE; PRIORITY JOURNAL; REVIEW; STEROIDOGENESIS; SYSTEMATIC REVIEW;

EID: 34147141587     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2641     Document Type: Review

References (63)

1. Zawadski J, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic ovary syndrome. Boston: Blackwell Scientific; 377-384
2. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19-25
3. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF 2006 Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab 91:4237-4245
4. Azziz R 2006 Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature. J Clin Endocrinol Metab 91:781-785
5. Franks S 2006 Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab 91:786-789
6. Franks S, Mason H, Willis D 2000 Follicular dynamics in the polycystic ovary syndrome. Mol Cell Endocrinol 163:49-52
7. Escobar-Morreale HF, Luque-Ramirez M, San Millan JL 2005 The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 26:251-282
8. Dunaif A 1997 Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 18:774-800
9. Poretsky L, Cataldo NA, Rosenwaks Z, Giudice LC 1999 The insulin-related ovarian regulatory system in health and disease. Endocr Rev 20:535-582
10. Poretsky L, Clemons J, Bogovich K 1992 Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cysts in rats. Metabolism 41:903-910
11. DeClue TJ, Shah SC, Marchese M, Malone JI 1991 Insulin resistance and hyperinsulinemia induce hyperandrogenism in a young type B insulin-resistant female. J Clin Endocrinol Metab 72:1308-1311
12. Fulghesu AM, Villa P, Pavone V, Guido M, Apa R, Caruso A, Lanzone A, Rossodivita A, Mancuso S 1997 The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab 82:644-648
13. De Leo V, la Marca A, Petraglia F 2003 Insulin-lowering agents in the management of polycystic ovary syndrome. Endocr Rev 24:633-667
14. Nestler JE, Barlascini CO, Matt DW, Steingold KA, Plymate SR, Clore JN, Blackward WG 1989 Suppression of serum insulin levels by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 68:1027-1032
15. Gambineri A, Patton L, De Iasio R, Cantelli B, Cognini GE, Filicori M, Barreca A, Diamanti-Kandarakis E, Pagotto U, Pasquali R 2005 Efficacy of octreotide-LAR in dieting women with abdominal obesity and polycystic ovary syndrome. J Clin Endocrinol Metab 90:3854-3862
16. Nagamani M, Van Dinh T, Kelver ME 1986 Hyperinsulinemia in hyperthecosis of the ovaries. Am J Obstet Gynecol 154:384-389
17. Dunaif A, Green G, Futterweit W, Dobrjansky A 1990 Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 70:699-704
18. Xita N, Tsatsoulis A 2006 Fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 91:1660-1666
19. Musso C, Cochran E, Moran SA, Skarulis MC, Oral EA, Taylor S, Gorden P 2004 Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective. Medicine 83:209-222
20. Taylor SI, Dons RF, Hernandez E, Roth J, Gorden P 1982 Insulin resistance associated with androgen excess in women with autoantibodies to the insulin receptor. Ann Intern Med 97:851-855
21. Satoh M, Yokoya S, Hachiya Y, Hachiya M, Fujisawa T, Hoshino K, Saji T 2001 Two hyperandrogenic adolescent girls with congenital portosystemic shunt. Eur J Pediatr 160:307-311
22. Murray RD, Davison RM, Russell RC, Conway GS 2000 Clinical presentation of PCOS following development of an insulinoma: case report. Hum Reprod 15:86-88
23. Nestler JE, Clore JN, Strauss 3rd JF, Blackard WG 1987 The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans. J Clin Endocrinol Metab 64:180-184
24. Halldin MU, Hagenas L, Tuvemo T, Gustafsson J 2000 Profound changes in the GH-IGF-I system in adolescent girls with IDDM: can IGFBP1 be used to reflect overall glucose regulation? Pediatr Diabetes 1:121-130
25. Cara JF, Rosenfield RL 1988 Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology 123:733-739
26. Yki-Jarvinen H, Koivisto VA 1986 Natural course of insulin resistance in type I diabetes. N Engl J Med 315:224-230
27. Rossetti L, Giaccari A, DeFronzo RA 1990 Glucose toxicity. Diabetes Care 13:610-630
28. Ahmed ML, Ong KK, Watts AP, Morrell DJ, Preece MA, Dunger DB 2001 Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes: longitudinal study during adolescence. J Clin Endocrinol Metab 86:1188-1193
29. Codner E, Barrera A, Mook-Kanamori D, Bazaes RA, Unanue N, Gaete X, Avila A, Ugarte F, Torrealba I, Perez V, Panteon E, Cassorla F 2004 Ponderal gain, waist-to-hip ratio, and pubertal development in girls with type-1 diabetes mellitus. Pediatr Diabetes 5:182-189
30. Bergquist N 1954 The gonadal function in female diabetics. Acta Endocrinol Suppl (Copenhagen) 19:3-20
31. Djursing H, Hagen C, Nyboe Andersen A, Svenstrup B, Bennett P, Molsted Pedersen L 1985 Serum sex hormone concentrations in insulin dependent diabetic women with and without amenorrhoea. Clin Endocrinol (Oxf) 23: 147-154
32. Djursing H, Nyholm HC, Hagen C, Carstensen L, Pedersen LM 1982 Clinical and hormonal characteristics in women with anovulation and insulin-treated diabetes mellitus. Am J Obstet Gynecol 143:876-882
33. Virdis R, Zampolli M, Street ME, Vanelli M, Potau N, Terzi C, Ghizzoni L, Ibanez L 1997 Ovarian 17α-hydroxyprogesterone responses to GnRH analog testing in oligomenorrheic insulin-dependent diabetic adolescents. Eur J Endocrinol 136:624-629
34. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF, Sheikh Z 1992 Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 327:157-162
35. Codner E, Mook-Kanamori D, Bazaes RA, Unanue N, Sovino H, Ugarte F, Avila A, Iniguez G, Cassorla F 2005 Ovarian function during puberty in girls with type 1 diabetes mellitus: response to leuprolide. J Clin Endocrinol Metab 90:3939-3945
36. Escobar-Morreale HF, Roldan B, Barrio R, Alonso M, Sancho J, de la Calle H, Garcia-Robles R 2000 High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 85:4182-4187
37. Codner E, Soto N, Lopez P, Trejo L, Avila A, Eyzaguirre FC, Iniguez G, Cassorla F 2006 Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 91:2250-2256
38. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF 2000 A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 85:2434-2438
39. Tellez R, Frenkel J 1995 Clinical evaluation of body hair in healthy women. Rev Med Chil 123:1349-1354
40. Schroeder B, Hertweck SP, Sanfilippo JS, Foster MB 2000 Correlation between glycemic control and menstruation in diabetic adolescents. J Reprod Med 45:1-5
41. Strotmeyer ES, Steenkiste AR, Foley Jr TP, Berga SL, Dorman JS 2003 Menstrual cycle differences between women with type 1 diabetes and women without diabetes. Diabetes Care 26:1016-1021
42. Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI 2006 Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 91:2100-2104
43. Danielson KK, Palta M, Allen C, D'Alessio DJ 2005 The association of increased total glycosylated hemoglobin levels with delayed age at menarche in young women with type 1 diabetes. J Clin Endocrinol Metab 90:6466-6471
44. Kjaer K, Hagen C, Sando SH, Eshoj O 1992 Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin-dependent diabetes mellitus compared to controls. J Clin Endocrinol Metab 75:524-529
45. Roldan B, Escobar-Morreale HF, Barrio R, de La Calle H, Alonso M, Garcia-Robles R, Sancho J 2001 Identification of the source of androgen excess in hyperandrogenic type 1 diabetic patients. Diabetes Care 24:1297-1299
46. Yki-Jarvinen H, Makimattila S, Utriainen T, Rutanen EM 1995 Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormonebinding globulin and insulin-like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab 80:3227-3232
47. Adcock CJ, Perry LA, Lindsell DR, Taylor AM, Holly JM, Jones J, Dunger DB 1994 Menstrual irregularities are more common in adolescents with type 1 diabetes: association with poor glycaemic control and weight gain. Diabet Med 11:465-470
48. Yeshaya A, Orvieto R, Dicker D, Karp M, Ben-Rafael Z 1995 Menstrual characteristics of women suffering from insulin-dependent diabetes mellitus. Int J Fertil Menopausal Stud 40:269-273
49. Meyer K, Deutscher J, Anil M, Berthold A, Bartsch M, Kiess W 2000 Serum androgen levels in adolescents with type 1 diabetes: relationship to pubertal stage and metabolic control. J Endocrinol Invest 23:362-368
50. Ibanez L, de Zegher F 2004 Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity. J Clin Endocrinol Metab 89:1592-1597
51. Garcia-Rudaz MC, Ropelato MG, Escobar ME, Veldhuis JD, Barontini M 2002 Amplified and orderly growth hormone secretion characterizes lean adolescents with polycystic ovary syndrome. Eur J Endocrinol 147:207-216
52. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV 1986 Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med 315:215-219
53. Amin R, Schultz C, Ong K, Frystyk J, Dalton RN, Perry L, Orskov H, Dunger DB 2003 Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study. Diabetes Care 26:1456-1461
54. Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP 1990 Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab 71:1356-1362
55. Bereket A, Lang CH, Wilson TA 1999 Alterations in the growth hormoneinsulin-like growth factor axis in insulin dependent diabetes mellitus. Horm Metab Res 31:172-181
56. Ehrmann DA 2005 Polycystic ovary syndrome. N Engl J Med 352:1223-1236
57. Rudberg S, Persson B 1995 Indications of low sex hormone binding globulin (SHBG) in young females with type 1 diabetes, and an independent association to microalbuminuria. Diabet Med 12:816-822
58. Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D 2003 Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care 26:138-143
59. Khan AS, McLoughney CR, Ahmed AB 2006 The effect of metformin on blood glucose control in overweight patients with type 1 diabetes. Diabet Med 23:1079-1084
60. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Zanolin E, Muggeo M 2000 Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 85:139-146
61. Ibanez L, de Zegher F 2005 Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy. J Clin Endocrinol Metab 90:39-43
62. Beckers D, Ahmed ML, Sancho PC, Acerini CL, Edge JA, De Zegher F, Ibanez L, Dunger DB 2006 Adolescent girls with T1DM, does combination treatment with flutamide and metformin make a difference? Pediatr Diabetes 7(Suppl 5):56
63. Sharpless JL 2005 Women's health issues in diabetes mellitus. In: Kahn CR, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ, eds. Joslin's diabetes mellitus. Philadelphia: Lippincott Williams, Wilkins; 747-764.